Scientists test One-Shot gene therapy to fight deadly brain cancer
Disease control
Ongoing
This early-stage study is testing the safety of a new, one-time gene therapy called Temferon for patients with a specific, hard-to-treat form of glioblastoma brain cancer. Doctors take a patient's own blood stem cells, genetically modify them to produce a cancer-fighting protein,…
Phase: PHASE1, PHASE2 • Sponsor: Genenta Science • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC